E

EternaTear

3 employees

EternaTear is developing a next-generation therapy for the over-the-counter dry eye market.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Health Care
Dry Eye
Consumer Health
Therapeutics
Medical
Pharmaceutical
Ophthalmology
OTC Pharmaceuticals

Date founded

2018

Funding rounds raised

Total raised

$4.9M

from 6 investors over 6 rounds

E

EternaTear raised $4.9M on October 11, 2020

Investors: Carolina Angel Network, FAN Fund, Keiretsu Capital, Band of Angels, Duke Angel Network and Keiretsu Forum / Capital

FAQ